Organization
Peking University Third Hospital
36 clinical trials
3 abstracts
Clinical trial
Multi-center Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot UlcerStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
The Effect of Topical 0.05% Cyclosporine Eye Drops on Post-refractive Surgery Dry EyeStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction: a Randomized Controlled StudyStatus: Active (not recruiting), Estimated PCD: 2025-01-01
Clinical trial
A Prospective, Single-Center, Open-Label Study of the Effect of Oral D-mannose Tablets on the Pharmacokinetics of Dabigatran Etexilate in Healthy AdultsStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
A Prospective Observational Cohort Study of Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical ProstatectomyStatus: Not yet recruiting, Estimated PCD: 2026-07-01
Clinical trial
AK104 Combined With Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Cervical CancerStatus: Not yet recruiting, Estimated PCD: 2025-01-11
Clinical trial
Clinical Efficacy Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic FootStatus: Not yet recruiting, Estimated PCD: 2024-06-30
Clinical trial
China Gender-affirming Hormone Therapy Study in Transgender Men and WomenStatus: Recruiting, Estimated PCD: 2027-12-31
Clinical trial
A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled Study to Evaluate Efficacy and Safety of Local Injection of Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients.Status: Recruiting, Estimated PCD: 2025-03-07
Clinical trial
Tetrandrine Tablets Used in Hospitalized Adults With COVID-19: a Double-blind, Placebo-controlled, Randomised TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-12
Clinical trial
Phase III Clinical Trial of Y-2 Sublingual Tablet in the Treatment of Acute Ischemic Stroke - a Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Clinical TrialStatus: Completed, Estimated PCD: 2022-08-10
Clinical trial
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic PatientsStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Randomized Double-blind Controlled Exploratory Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS PatientsStatus: Recruiting, Estimated PCD: 2027-09-30
Clinical trial
A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+)Status: Not yet recruiting, Estimated PCD: 2025-04-30
Clinical trial
A Single-arm, Open-label Exploratory Clinical Study to Assess the Preliminary Safety of the Gene Editing Drug ZVS203e for the Management of Retinitis Pigmentosa Caused by Mutations in the RHO GeneStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Multicenter, Single-arm, Prospective Study of SBRT Combined With Zimberelimab (GLS-010) in Patients With Locally Advanced Pancreatic Cancer (SPARK-1 Study)Status: Not yet recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Randomized Controlled Clinical Study of Early Application of Levosimendan to Improve Cardiac Dysfunction and Neurological Prognosis in Patients With Cardiac ArrestStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Prospective, Multicenter, Single Arm Study of SBRT Combined With Nimotuzumab and Mono-chemotherapy in the Treatment of Locally Advanced Pancreatic CancerStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer:A Multicentre, Single-arm, Phase II Trial.Status: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
A Retrospective Clinical Study of Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Carcinoma.Status: Completed, Estimated PCD: 2023-05-21
Clinical trial
Evaluation of the Effect of Triamcinolone at Different Doses on Local Infiltration Anesthesia During Total Knee ArthroplastyStatus: Active (not recruiting), Estimated PCD: 2024-02-12
Clinical trial
Clinical Study of Stereotactic Body Radiotherapy Combined With Cadonilimab for the Treatment of Advanced Refractory Malignant Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2024-06-21
Clinical trial
Clinical Study of Combined Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic TherapyStatus: Recruiting, Estimated PCD: 2028-12-30
Clinical trial
A Randomized, Double-blind, Blank Controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Tolerability of Initial Periodontal Therapy Combined With Human Dental Pulp Stem Cell Injection in the Treatment of Chronic PeriodontitisStatus: Active (not recruiting), Estimated PCD: 2024-07-31
Clinical trial
A Controlled Clinical Study of Envafolimab (PD-L1 Antibody) Subcutaneous Injection Combined With Endostar and Concurrent Chemoradiotherapy in Treatment of Locally Advanced Primary Cervical CancerStatus: Not yet recruiting, Estimated PCD: 2024-05-16
Clinical trial
Immediate Versus Postponed Freeze-all Embryo Transfer in Hyperresponders, A Multicenter Randomised Controlled TrialStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Single Center, Open Label Study of Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker for Drug-metabolizing Enzymes and Transporters in Chinese Older AdultsStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
Effect of Metformin Intervention on Patients With Polycystic Ovary SyndromeStatus: Completed, Estimated PCD: 2022-06-01
Clinical trial
Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease: A Multi-center, Prospective StudyStatus: Not yet recruiting, Estimated PCD: 2025-02-01
Clinical trial
Intrauterine Insemination With Letrozole Versus Intrauterine Insemination in Natural Cycle. A Muticenter Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment PatientsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Randomized Controlled Clinical Trial of Effectiveness of Yunnan Baiyao in Improving Fracture PainStatus: Not yet recruiting, Estimated PCD: 2023-12-31
Clinical trial
An Exploratory Clinical Study on Single Subretinal Injection of ZVS101e (rAAV2/8-hCYP4V2) Into Eyes With Bietti's Crystalline Dystrophy (BCD)Status: Recruiting, Estimated PCD: 2025-03-31
Clinical trial
Clinical Evaluation of Enteral-extended Anti-reflux Stents for Pancreatic PseudocystStatus: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
Correlation Between Early Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug TherapyStatus: Recruiting, Estimated PCD: 2023-06-01
Clinical trial
Correlation Between Early Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive and Curative Effects of ProbioticsStatus: Not yet recruiting, Estimated PCD: 2023-07-01
Abstract
Preliminary results from a phase I/II study of IMM0306, a CD47 and CD20 bispecific monoclonal antibody-trap, in patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma.Org: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China, The First Affiliated Hospital of Zhengzhou University,
Abstract
Jaktinib in patients (pts) with myelofibrosis (MF) who were intolerant to ruxolitinib (RUX): An open-label, single-arm phase 2b study.Org: The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei, China, College of Medicine, University of the Philippines - Manila, Zhejiang University, Hangzhou, China, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, Winship Cancer Institute of Emory University, Atlanta, GA, Emory University, Atlanta, GA, Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, Department of Medicine, Massachusetts General Hospital, Boston, MA, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Urology, Emory University School of Medicine, Atlanta, GA, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China,
Abstract
Clinical outcomes of patients with advanced NSCLC with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors.Org: Peking University Third Hospital, Yanan City Hospital of Traditional Chinese Medicine,